SLNO logo

Soleno Therapeutics (SLNO) Current Assets

Annual Current Assets

$171.36 M
+$155.71 M+995.15%

31 December 2023

SLNO Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Current Assets

$258.20 M
-$9.30 M-3.48%

30 September 2024

SLNO Quarterly Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

SLNO Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+995.1%+381.2%
3 y3 years+241.1%+793.8%
5 y5 years+594.6%+2124.1%

SLNO Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+995.1%-3.5%+2729.0%
5 y5 yearsat high+995.1%-3.5%+2729.0%
alltimeall timeat high>+9999.0%-3.5%>+9999.0%

Soleno Therapeutics Current Assets History

DateAnnualQuarterly
Sept 2024
-
$258.20 M(-3.5%)
June 2024
-
$267.50 M(+76.9%)
Mar 2024
-
$151.22 M(-11.8%)
Dec 2023
$9.33 M(-14.0%)
$171.36 M(+219.3%)
Sept 2023
-
$53.66 M(+161.8%)
June 2023
-
$20.50 M(+124.6%)
Mar 2023
-
$9.13 M(-41.7%)
Dec 2022
$10.85 M(-17.4%)
$15.65 M(-23.9%)
Sept 2022
-
$20.57 M(-17.3%)
June 2022
-
$24.89 M(-17.0%)
Mar 2022
-
$29.98 M(+33.7%)
Dec 2021
$13.13 M(-10.9%)
$22.42 M(-22.4%)
Sept 2021
-
$28.89 M(-16.4%)
June 2021
-
$34.54 M(-18.8%)
Mar 2021
-
$42.53 M(-15.4%)
Dec 2020
$14.74 M(-13.4%)
$50.24 M(-11.1%)
Sept 2020
-
$56.48 M(-10.3%)
June 2020
-
$63.00 M(+302.8%)
Mar 2020
-
$15.64 M(-26.0%)
Dec 2019
$17.03 M
$21.14 M(+82.1%)
Sept 2019
-
$11.61 M(-30.1%)
June 2019
-
$16.61 M(-20.4%)
DateAnnualQuarterly
Mar 2019
-
$20.86 M(-15.4%)
Dec 2018
$18.48 M(-12.1%)
$24.67 M(+116.2%)
Sept 2018
-
$11.41 M(-14.3%)
June 2018
-
$13.31 M(-15.8%)
Mar 2018
-
$15.81 M(-12.1%)
Dec 2017
$21.03 M(+1092.3%)
$17.99 M(+181.6%)
Sept 2017
-
$6.39 M(-38.1%)
June 2017
-
$10.32 M(-12.6%)
Mar 2017
-
$11.80 M(+210.4%)
Dec 2016
$1.76 M(-1.9%)
$3.80 M(-41.6%)
Sept 2016
-
$6.51 M(+73.2%)
June 2016
-
$3.76 M(-50.5%)
Mar 2016
-
$7.58 M(+18.4%)
Dec 2015
$1.80 M(+3019.6%)
$6.40 M(+15.9%)
Sept 2015
-
$5.53 M(-32.3%)
June 2015
-
$8.16 M(-18.5%)
Mar 2015
-
$10.02 M(+20.2%)
Dec 2014
$57.60 K(-8.9%)
$8.34 M(+2616.1%)
Sept 2014
-
$307.00 K(-78.6%)
June 2014
-
$1.43 M(+45.0%)
Mar 2014
-
$987.00 K(-35.2%)
Dec 2013
$63.20 K(-50.0%)
$1.52 M
Dec 2012
$126.50 K
-

FAQ

  • What is Soleno Therapeutics annual total current assets?
  • What is the all time high annual current assets for Soleno Therapeutics?
  • What is Soleno Therapeutics annual current assets year-on-year change?
  • What is Soleno Therapeutics quarterly total current assets?
  • What is the all time high quarterly current assets for Soleno Therapeutics?
  • What is Soleno Therapeutics quarterly current assets year-on-year change?

What is Soleno Therapeutics annual total current assets?

The current annual current assets of SLNO is $171.36 M

What is the all time high annual current assets for Soleno Therapeutics?

Soleno Therapeutics all-time high annual total current assets is $171.36 M

What is Soleno Therapeutics annual current assets year-on-year change?

Over the past year, SLNO annual total current assets has changed by +$155.71 M (+995.15%)

What is Soleno Therapeutics quarterly total current assets?

The current quarterly current assets of SLNO is $258.20 M

What is the all time high quarterly current assets for Soleno Therapeutics?

Soleno Therapeutics all-time high quarterly total current assets is $267.50 M

What is Soleno Therapeutics quarterly current assets year-on-year change?

Over the past year, SLNO quarterly total current assets has changed by +$204.54 M (+381.18%)